Detalhe da pesquisa
1.
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents.
Nature;
553(7687): 217-221, 2018 01 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29258297
2.
In Vivo Assessment of Potential Therapeutic Approaches for USH2A-Associated Diseases.
Adv Exp Med Biol;
1185: 91-96, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31884594
3.
Intervention with metabolites emulating endogenous cell transitions accelerates muscle regeneration in young and aged mice.
Cell Rep Med;
5(3): 101449, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38508141
4.
Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo.
Nat Commun;
14(1): 4928, 2023 08 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37582836
5.
Ablation of the auditory cortex results in changes in the expression of neurotransmission-related mRNAs in the cochlea.
Hear Res;
346: 71-80, 2017 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28216123
6.
Stereotactically-guided Ablation of the Rat Auditory Cortex, and Localization of the Lesion in the Brain.
J Vis Exp;
(128)2017 10 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29053697
7.
Acoustic input and efferent activity regulate the expression of molecules involved in cochlear micromechanics.
Front Syst Neurosci;
8: 253, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25653600
8.
Long-term evolution of brainstem electrical evoked responses to sound after restricted ablation of the auditory cortex.
PLoS One;
8(9): e73585, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24066057